SCHEMBL3494992

SCHEMBL3494992

COCC(=O)Nc1ccc(C=O)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.44
ALDH1A1 P00352 5/20 0.44
TSHR P16473 1/20 0.43
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPK1 P28482 2/20 0.42
CYP2C19 P33261 1/20 0.42
ALOX12 P18054 1/20 0.42
HTT P42858 1/20 0.42
TP53 P04637 2/20 0.41
HSD17B10 Q99714 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2A1 P68400 1/20 0.40
KMT2A Q03164 1/20 0.40
AHR P35869 1/20 0.40
LMNA P02545 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3493473 0.78 CSNK2A2 (0.43) HPGDALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL1433832 0.76 HSD17B10 (0.67) ALDH1A1TSHRMAPTSMN1; SMN2MAPK1
SCHEMBL3493311 0.73 ALDH1A1 (0.48) HPGDALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL3493109 0.71 ALDH1A1 (0.48) HPGDALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL22783473 0.71 L3MBTL1 (0.52) HPGDALDH1A1NPC1KDM4E
SCHEMBL2282492 0.69 HPGD (0.65) HPGDALDH1A1MAPTSMN1; SMN2MAPK1
SCHEMBL14962804 0.68 HPGD (0.81) HPGDALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL21334347 0.68
SCHEMBL13841464 0.68 SMN1; SMN2 (0.50) HPGDALDH1A1TSHRMAPTSMN1; SMN2
SCHEMBL2226671 0.66 NPSR1 (0.53) HPGDALDH1A1TSHRMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
EP-1857455-A1 CINNAMOYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed
EP-1857455-A1 CINNAMOYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081652-A1 Cinnamoyl Compound and Use Thereof COL2A1, MMP7, COL14A1 HPGD 1386/4885ALDH1A1 474/4885TSHR 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.